Sumitomo Pharma Co Ltd
SWB:DPM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sumitomo Pharma Co Ltd
SWB:DPM
|
JP |
|
P
|
PROG Holdings Inc
F:AZD
|
US |
|
Agora Inc
NASDAQ:API
|
US |
|
Talgo SA
F:XTG
|
ES |
Intrinsic Value
Is DPM undervalued or overvalued?
See the intrinsic value estimate for 
Sumitomo Pharma Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
DPM looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with DPM’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Sumitomo Pharma Does
Sumitomo Pharma is a Japanese drug company that develops, makes, and sells prescription medicines. Its business centers on medicines for patients with conditions such as mental health disorders, cancer, diabetes, Parkinson’s disease, and urology-related illnesses. It also works on drug discovery and clinical development, which means it spends money to find new medicines, test them, and bring them to market.
- Headquarters
- Japan JP
- Employees
- 3 832
- IPO date
- May 16, 1949
Revenue & Expenses Breakdown
Sumitomo Pharma Co Ltd
Earnings Waterfall
Sumitomo Pharma Co Ltd
The intrinsic value for Sumitomo Pharma Co Ltd (DPM) under the Base Case is hidden EUR.
Compared with the current market price of 6.519 EUR, the stock appears hidden.